Company: BUDZ
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001096906-25-001331
Chunk: 26

Company: WEED, INC.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 26
---
, with a globally-recognized brand focusing on building and purchasing labs, land and building commercial grade “Cultivation Centers” to consult, assist, manage & lease to universities, state governments, licensed dispensary owners and organic grow operators on a contract basis with a concentration on the legal and medical cannabis sector.

Our long-term plan is to become a true “Seed-to-Sale” global holding company providing infrastructure, financial solutions, product development, and real estate options in this new emerging market. Our long term growth may also come from the acquisition of synergistic businesses, such as distilleries, to make anything from infused beverages to super oxygenated water with CBD and THC. Currently, we have formed WEED Australia Ltd., registered as an unlisted public company in Australia to address this Global demand. We have also formed WEED Israel Cannabis Ltd., an Israeli corporation, to address future global demand. We will look to conduct future research, marketing, import/exporting, and manufacturing of our proprietary products on an international level.

On April 20, 2017, we entered into a Share Exchange Agreement with Sangre AT, LLC, a Wyoming limited liability company, under which we acquired all of the issued and outstanding limited liability company membership units of Sangre in exchange for Five Hundred Thousand (500,000) shares of our common stock, restricted in accordance with Rule 144. As a result of this agreement, Sangre is a wholly-owned subsidiary of WEED, Inc.

This discussion and analysis should be read in conjunction with our financial statements included as part of this Quarterly Report.

 22Table of Contents

Three Months Ended June 30, 2025 Compared to Three Months Ended June 30, 2024

Results of Operations

  Three Months Ended   June 30,   2025  2024 Revenue $-  $-          Operating expenses:                 General and administrative  64,052   85,296 Professional fees  24,372   51,474 Depreciation and amortization  5,621   8,185 Total operating expenses  95,045   144,955          Net operating loss  (94,045 )  (144,955 )         Other income (expense)        Interest expense  (13,571 )  (599 )Other income  -   35,000 Total other income (expense) $13,571 )